EUVIMEDEUVIMED entdecken
Open Access

68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging

Fangyuan Ren, Hongyang Jiang, Lin Shi, Lan Zhang, Xiao Li iD, Qinkang Lu, Qiang Li

European Journal of Nuclear Medicine and Molecular Imaging · 2023

DOI: 10.1007/s00259-023-06159-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Fangyuan Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Department of Radiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, 3100…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shanghai "Rising Stars of Medical Talent" Youth Development Program, Shanghai “Rising Stars of Medical Talent” Youth Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: For the tumor-specific ACE2 expression, this research aimed to establish and verify ACE2-targeted PET imaging in differentiating tumors with distinct ACE2 expression. METHODS: 68Ga-cyc-DX600 was synthesized as tracer of ACE2 PET. NOD-SCID mice were used to prepare the subcutaneous tumor models with HEK-293 or HEK-293T/hACE2 cells to verify ACE2 specificity, with other kinds of tumor cells to evaluate the diagnostic efficiency for ACE2 expression, additionally, immunohistochemical analysis and western blot were used to certify the findings on ACE2 PET, which was then performed on four cancer patients and compared with FDG PET. RESULTS: The metabolic clearance of 68Ga-cyc-DX600 was initially completed in 60 min, realizing an ACE2-dependent and organ-specific background of ACE2 PET; meanwhile, tracer uptake of subcutaneous tumor models was of a definite dependence on ACE2 expression (r = 0.903, p < 0.05), and the latter served as the primary factor when ACE2 PET was used for the differential diagnosis of ACE2-related tumors. In pre-clinical practice, a comparable tumor-to-background ratio was acquired in ACE2 PET of a lung cancer patient at 50 and 80 min post injection; the quantitative values of ACE2 PET and FDG PET were negatively correlated (r = - 0.971 for SUVmax, p = 0.006; r = - 0.994 for SUVmean, p = 0.001) in an esophageal cancer patient, no matter the primary lesion or metastasis. CONCLUSIONS: 68Ga-cyc-DX600 PET was an ACE2-specific imaging for the differential diagnosis of tumors and added complementary value to conventional nuclear medicine diagnosis, such as FDG PET on glycometabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLung NeoplasmsAnimalsMiceHumansGallium RadioisotopesAngiotensin-Converting Enzyme 2Fluorodeoxyglucose F18HEK293 CellsMice, Inbred NODMice, SCID

Stichwörter der Autor:innen

68Ga-cyc-DX600ACE2Differential diagnosisRAASTumor

Substanzen

Gallium RadioisotopesAngiotensin-Converting Enzyme 2Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Cancer Center, Department of Radiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, 310014, Hangzhou, China.
  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, China.
  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, China. lixiao_nm@smmu.edu.cn.
  • Department of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 200032, China. lixiao_nm@smmu.edu.cn.
  • Department of Radiology, The Affiliated People's Hospital of Ningbo University, Zhejiang, 315040, Ningbo, China. luqinkang@163.com.
  • Department of Radiology, The Affiliated People's Hospital of Ningbo University, Zhejiang, 315040, Ningbo, China. rmliqiang@nbu.edu.cn.

ORCID-Profile: Xiao Li

Förderung

  • Shanghai "Rising Stars of Medical Talent" Youth Development Program
  • Shanghai “Rising Stars of Medical Talent” Youth Development Program

Zitieren

APA

Ren, F., Jiang, H., Shi, L., Zhang, L., Li, X., Lu, Q., & Li, Q. (2023). 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06159-7

Vancouver

Ren F, Jiang H, Shi L, Zhang L, Li X, Lu Q, et al. 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06159-7

BibTeX
@article{Ren2023,
  author = {Ren, Fangyuan and Jiang, Hongyang and Shi, Lin and Zhang, Lan and Li, Xiao and Lu, Qinkang and Li, Qiang},
  title = {68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  doi = {10.1007/s00259-023-06159-7}
}
Kostenlos starten →